
Reset all filters
01 1DICLOFENAC SODIUM
02 1LEVETIRACETAM
03 3MORPHINE SULFATE
04 1MS CONTIN
05 1RITALIN-SR
Reset all filters
01 118029
02 119516
03 174769
04 174862
05 176201
06 1202167
07 1203849
Reset all filters
01 7No
Drug : MORPHINE SULFATE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 203849
Country : US
Patented : No
Drug : DICLOFENAC SODIUM
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 76201
Country : US
Patented : No
Drug : RITALIN-SR
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 18029
Country : US
Patented : No
Drug : MS CONTIN
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 19516
Country : US
Patented : No
Drug : MORPHINE SULFATE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 74862
Country : US
Patented : No
Drug : MORPHINE SULFATE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 74769
Country : US
Patented : No
Drug : LEVETIRACETAM
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 202167
Country : US
Patented : No
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF